...
首页> 外文期刊>American Journal of Surgical Pathology >Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases.
【24h】

Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases.

机译:免疫组化评估I期大肠癌淋巴管浸润:预后的相关性和与淋巴结微转移的相关性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Several studies have suggested that the presence of occult nodal metastases (micrometastases) is related to adverse clinical course in stage I colorectal carcinoma. Herein we analyzed the correlation between nodal micrometastases and lymphovascular invasion (LVI) or lymphatic vessel density (LVD) in a series of stage I colorectal carcinomas; the cohort included cases characterized or not characterized by disease progression during the follow-up. In these cases, LVI and LVD were evidenced through the immunohistochemical detection of the specific marker for lymphatic vessels, D2-40. LVI was significantly more frequent in colorectal carcinomas characterized by the presence of micrometastases (P<0.0001), high peritumoral LVD (P<0.0001), and disease progression (P<0.0001). The analysis for progression risk indicated that nodal micrometastases and LVI were significant, negative, independent prognostic parameters associated with shorter disease-free survival of stage I colorectal cancer (P=0.0001; P=0.0242). In conclusion, in this study we demonstrated for the first time that LVI is significantly associated with nodal occult metastases in stage I colorectal carcinoma. In the light of its significant, independent, prognostic value in this neoplasia, the detection of LVI may represent a faster and cheaper tool compared with the time-consuming evaluation of micrometastases to select high-risk patients who may benefit from adjuvant systemic treatment. Furthermore, the assessment of LVI may be applied to establish the likelihood of nodal involvement from carcinomas treated with conservative local excision techniques, which provide no regional nodes for histologic examination.
机译:几项研究表明,隐匿性淋巴结转移(微转移)的存在与I期大肠癌的不良临床进程有关。本文分析了一系列I期结直肠癌的淋巴结微转移与淋巴管浸润(LVI)或淋巴管密度(LVD)之间的相关性。该队列包括随访期间以疾病进展为特征或没有特征的病例。在这些情况下,通过免疫组织化学检测淋巴管D2-40的特异性标记物可以证明LVI和LVD。 LVI在以微转移(P <0.0001),高瘤周LVD(P <0.0001)和疾病进展(P <0.0001)为特征的大肠癌中更为常见。进展风险分析表明,结节微转移灶和LVI是与I期大肠癌无病生存期较短相关的显着,阴性,独立的预后参数(P = 0.0001; P = 0.0242)。总之,在这项研究中,我们首次证明了LVI与I期结直肠癌的淋巴结隐匿性转移显着相关。鉴于其在这种瘤形成中的重要,独立的预后价值,与耗时的微转移评估相比,LVI的检测可能代表了一种更快,更便宜的工具,从而可以选择可以从辅助全身治疗中受益的高危患者。此外,对LVI的评估可用于确定采用保守的局部切除技术治疗的癌的淋巴结受累的可能性,该技术未提供用于组织学检查的区域性淋巴结。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号